Table 2.

Patient demographics

CharacteristicDose escalation (n = 37)Expansion (n = 11)
Age, y
Median61.465.0
Range25–8238–77
Sex, n (%)
Male20 (54.1)6 (54.5)
Female17 (45.9)5 (45.5)
Race/ethnicity, n (%)
 Caucasian33 (89.2)9 (81.8)
 African-American1 (2.7)2 (18.2)
 Hispanic1 (2.7)
 Other2 (5.4)
Diagnosis, n (%)
Multiple myeloma21 (56.8)7 (63.6)
Secretory19 (51.4)7 (63.6)
  Nonsecretory2 (5.4)
Lymphoma16 (43.2)2 (18.2)
  Mantle cell6 (16.2)
  Follicular6 (16.2)
  Diffuse large cell2 (5.4)1 (9.1)
  T-cell1 (9.1)
  SLL/CLL1 (2.7)
  Hodgkin lymphoma1 (2.7)
 Waldenström's macroglobulinemia2 (18.2)
Years since diagnosis
 Median3.97.0
 Range0.7–13.73.1–22.9

Abbreviations: MM, multiple myeloma; SLL/CLL, small lymphocytic lymphoma/chronic lymphocytic leukemia.